This Solicitation opportunity from Department Of Health And Human Services was posted on June 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Technology InteGrator and AcceleratoR (TIGAR)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Technology InteGrator and AcceleratoR (TIGAR) solicitation issued by the Advanced Research Projects Agency for Health (ARPA-H) seeks innovative solutions focused on developing enabling technologies that support temperature-flexible storage of regenerative tissues and organs. The goal is to achieve breakthrough advances that allow for stabilized storage and distribution of increasingly large and complex biologics without incurring high cost or complexity. Proposals can integrate approaches such as new materials, artificial intelligence, biological interventions, devices, and packaging methods that reduce reliance on controlled temperature environments while ensuring safety and shelf-life stability at manageable, ideally non-cryogenic, temperatures. Innovations must be applicable beyond the cellular level, extending to deployment in thick tissues. Recent amendments clarify submission requirements by adding detailed instructions on how to submit Solution Videos, including formatting and captioning guidelines, and simplifying supplemental slide templates with a new Cost Summary slide. Terminology was refined for accuracy, and updated administrative policies were incorporated. The solicitation opened on May 14, 2026, with responses due by June 8, 2026, and includes updated webinar dates for proposer engagement. The focus of the funding opportunity centers on overcoming logistical challenges in biologic storage, with a preference for strategies enabling temperature flexibility and stable preservation under varying environmental conditions. Interested parties are encouraged to monitor for updates and refer to specific notices for event registration and further information.
General Info
Agency
NAICS
Place of Performance
Washington, DC, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
Amendment 3
(1) Appendix B was updated to remove track changes
(2) Appendix C4 was updated to remove an erroneous comment.
Amendment 2
(1) Instructions on how to submit a Solution Video were added to the ISO (see pages 7-8).
(2) Information related to the Video Captions file was added to Appendix B.0 (Solution Video Format and Instructions).
(3) The instructions in Appendix B.1 (Template for Supplemental Slides) were simplified, and a Cost Summary slide was added (see Slide 7).
(4) Appendix C.3 was updated to reference "Phase" rather than "Year" for clarity.
(5) The Administation and National Policy document in Appendix C.4 was replaced with an updated document.
Amendment 1
The ISO was updated with the new webinar and webinar registration dates.
Effort Description:
TIGAR Exploratory Topic will forge entirely new paths to stabilizing regenerative tissues and organs by seeding the development of enabling technologies that can unlock temperature-flexible storage in increasingly larger and more complex biological systems. Solutions may involve any combination of new materials, artificial intelligence/machine learning, high-throughput screening methods, biological interventions, devices, processing methods, analytical technology, and packaging approaches that can overcome current roadblocks and yield a leap in the ability to store and distribute complex biologics, without introducing high cost or complexity. Strategies that reduce reliance on strictly controlled temperature zones and can ensure safe storage in a range of environmental conditions are preferred. While long-term temperature-flexible storage is ideal, any advance that removes logistical hurdles or establishes shelf-life stability at easy to maintain temperatures (preferably non-cryogenic) will be considered. Innovations at the cellular level without a strategy for deployment in thick tissues will not be considered.
Please ensure to follow this opportunity for any updates.
For more information on the TIGAR Exploratory Topic visit: https://arpa-h.gov/explore-funding/initiatives-and-sprints/tigar
For information on Proposer's Day details and registration information, please see Special Notice ARPA-H-SN-26-142